Sopharma : Information according to Annex 9 of Ordinance 2 as at 30 June 2021

August 30, 2021 at 08:42 am EDT

Annex 9

To Art. 33, Par. 1, item 3 of Ordinance № 2 from 17.09.2003

Facts and circumstances to disclosed

as at 30.06.2021 for issuers

Sopharma Group

1.1. Change of the persons exercising control over the company. No change - no such people.

No opening of bankruptcy proceedings against the Company or its subsidiary or any significant events related to production.
Conclusion or execution of significant transactions

There are no significant transactions beyond the ordinary course of business.

1.8. There are no agreements for conclusion, termination and cancellation of joint venture.

On March 15, 2021 at its meeting the Board of Directors of the Company decided to conclude a general policy agreement for the management of "Momina Krepost" AD with "Medical Consumables" OOD holding 56.59% of the votes in the General Meeting of "Momina Krepost" AD by joint exercise of voting rights. The parties will coordinate their actions on all significant issues concerning the company's activities, such as transformation or termination of the company, changes in the amount of the company's capital, amendments or supplements to the Articles of Association, changes in the composition of management bodies, staff and conditions on employment contracts, the main activity and the financial strategy of the company, etc.

On 7 June 2021 Sopharma AD terminated its agreement for joint management of Sopharma Buildings REIT with Donev investments holding AD.

1.10. There is no change in the company's auditors and no reasons for the change.
No initiation or termination of a court or arbitration proceedings relating to claims or liabilities of the Company or its subsidiary, with the price of the claim at least 10% of the Company's equity.
Purchase, sale or pledge of shares in companies of the issuer or its subsidiary

The structure of the Group includes "Sopharma" AD as a parent company and the subsidiaries

stated below:

Subsidiaries	30.06.2021	31.12.2020	Date of	Date of
acquisition
			acquisition
Companies in Bulgaria	Interest %	Interest %	of control /
of control
inlowing

"Sopharma Trading" AD	76.33	76.17	08.06.2006
"Pharmalogistica" AD	89.39	89.39	15.08.2002
"Electroncommerce" EOOD	100.00	100.00	09.08.2005
"Biopharm Engineering" AD	97.15	97.15	10.03.2006
"Sopharma Buildings" REIT	-	40.38	04.08.2008	07.06.2021

This is a translation from Bulgarian of the consolidated financial statements of Sopharma Group for the first half of 2021.

In case of divergence Bulgarian text should prevail.

"Momina Krepost" AD	-	60.93	01.01.2008	10.03.2021
"Phyto Palauzovo" AD	95.00	95.00	21.09.2012
"Veta Pharma" AD	99.98	99.98	11.11.2016
"Aromania" AD	-	-	31.07.2017	23.12.2020
"Sopharmacy" EOOD**	76.33	76.17	19.01.2015
"Sopharmacy 2" EOOD**	76.33	76.17	17.06.2015
"Sophar macy 3" EOOD**	76.33	76.17	02.12.2015
"Sopharmacy 4" EOOD**	76.33	76.17	29.02.2016
"Sopharmacy 5" EOOD**	76.33	76.17	01.03.2016
"Sopharmacy 6" EOOD**	76.33	76.17	03.12.2015
"Sopharmacy 7" EOOD**	76.33	76.17	15.03.2017
"Sopharmacy 8" EOOD**	76.33	76.17	27.06.2017
"Sopharmacy 9" EOOD**	76.33	76.17	11.09.2017
"Sopharmacy 10" EOOD**	76.33	76.17	11.09.2017
"Sopharmacy 11" EOOD	76.33	76.17	07.12.2017
"Sopharmacy 12" EOOD	76.33	76.17	07.12.2017
"Sopharmacy 13" EOOD	76.33	76.17	07.12.2017
"Sopharmacy 14" EOOD	76.33	76.17	07.12.2017
"Sopharmacy 15" EOOD	76.33	76.17	07.12.2017
"Sopharmacy 16" EOOD **	76.33	76.17	15.05.2018
"Sopharmacy 17" EOOD **	76.33	76.17	15.05.2018
"Sopharmacy 18" EOOD **	76.33	76.17	28.02.2019
"Sanita Franchising" AD**	76.33	76.17	01.10.2020
"Sopharmacy 19" EOOD	76.33
(Valentina Vasileva - Lyulin		76.17	01.10.2020
EOOD) **
"Sopharmacy 20" EOOD (Vasilka	76.33	76.17	01.10.2020
Lilovska EOOD) **

"Sopharmacy 21" EOOD (Venera	76.33	76.17	01.10.2020
Mutashka EOOD) **

"Sopharmacy 22" EOOD (Veselka	76.33	76.17	01.10.2020
Vasileva EOOD) **

"Sopharmacy 23" EOOD (Victoria	76.33	76.17	01.10.2020
Angelova EOOD) **

"Sopharmacy 24" EOOD	76.33	76.17	01.10.2020
(Desislava Jordanova EOOD) **

"Sopharmacy 25" EOOD (Dimka	76.33	76.17	01.10.2020
Vladeva EOOD) **

"Sopharmacy 26" EOOD (Donka	76.33	76.17	01.10.2020
Chivganova EOOD) **

"Sopharmacy 27" EOOD (Ekaterina	76.33	76.17	01.10.2020
Mihaylova - Shumen 1 EOOD) **

"Sopharmacy 19" EOOD	76.33
(Valentina Vasileva - Lyulin		76.17	01.10.2020
EOOD) **
"Sopharmacy 20" EOOD (Vasilka	76.33	76.17	01.10.2020
Lilovska EOOD) **

"Sopharmacy 21" EOOD (Venera	76.33	76.17	01.10.2020
Mutashka EOOD) **

This is a translation from Bulgarian of the consolidated financial statements of Sopharma Group for the first half of 2021.

In case of divergence Bulgarian text should prevail.

"Sopharmacy 22" EOOD (Veselka Vasileva EOOD) ** "Sopharmacy 23" EOOD (Victoria Angelova EOOD) ** "Sopharmacy 24" EOOD (Desislava Jordanova EOOD) ** "Sopharmacy 25" EOOD (Dimka Vladeva EOOD) ** "Sopharmacy 26" EOOD (Donka Chivganova EOOD) ** "Sopharmacy 27" EOOD (Ekaterina Mihaylova - Shumen 1 EOOD) **

"Sopharmacy 28" EOOD (Elka Neykova EOOD) ** "Sopharmacy 29" EOOD (Emilia Angelova EOOD) ** "Sopharmacy 30" EOOD (Juliana Kotova EOOD) ** "Sopharmacy 31" EOOD (Ivan Ivanov 1 EOOD) ** "Sopharmacy 32" EOOD (Iliana Kalushkova EOOD) ** "Sopharmacy 33" EOOD (Irina Toncheva EOOD) ** "Sopharmacy 34" EOOD (Kapka Nikolova - Military Hospital EOOD) **

"Sopharmacy 35" EOOD (Kostadin Gorchev EOOD) ** "Sopharmacy 36" EOOD (Krasimira Shunina EOOD) ** "Sopharmacy 37" EOOD (Lora Doncheva EOOD) ** "Sopharmacy 38" EOOD (Lyudmila Zlatkova EOOD) ** "Sopharmacy 39" EOOD (Lyudmila Kovacheva EOOD) ** "Sopharmacy 40" EOOD (Manik Burgazyan EOOD) ** "Sopharmacy 41" EOOD (Mariyka Jaigarova EOOD) ** "Sopharmacy 42" EOOD (Mariya Agova EOOD) ** "Sopharmacy 43" EOOD (Mariya Gancheva EOOD) **

"Sopharmacy 44" (Maria Kenova EOOD) **

"Sopharmacy 45" (Maria Hristova

Motopista EOOD) **

"Sopharmacy 46" (Mariana Markova EOOD) ** "Sopharmacy 47" (Mery Ivanova EOOD) **

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33

76.17 01.10.2020

76.33 76.17 01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33

76.17 01.10.2020

76.33 76.17 01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

This is a translation from Bulgarian of the consolidated financial statements of Sopharma Group for the first half of 2021.

In case of divergence Bulgarian text should prevail.

"Sopharmacy 48" (Nelly Stavreva EOOD) **

"Sopharmacy 49"( Preslava Becheva EOOD) ** "Sopharmacy 50" (Rayna Madzharova - St. Georgi Sofiyski EOOD) **

"Sopharmacy 51" (Rumyana Ignatova - Gancheva EOOD) ** "Sopharmacy 52" (Sashka Todorova EOOD) ** "Sopharmacy 53" (Svetlana Harizanova EOOD) ** "Sopharmacy 54" (Svetlana Pirpidonova EOOD) ** "Sopharmacy 55" (Ceiba- Blagoevgrad-1 EOOD) ** "Sopharmacy 56" (Silvia Veneva EOOD) **

"Sopharmacy 57" (Siyana Milanova EOOD) ** "Sopharmacy 58" (Stoyanka Radenkova EOOD) ** "Sopharmacy 59" (Ana Avdzhieva EOOD) **

"Sopharmacy 60" (Radina Bekova EOOD) **

"Sopharmacy 61" (Rumen Raynov EOOD) **

"Sopharmacy 62" (Hani Modhi EOOD) **

"Sopharmacy 63" (SCS Franchise EAD)

effective percentage of interest
indirect interest

Subsidiaries

Companies abroad

SIA "Briz"

SOOO "Brititrade" ** PAO "Vitamini"

"Sopharma Warsaw" SP. Z.O.O.

"Sopharma Trading Pharmaceuticals" **("Sopharma Trading" d.o.o. Belgrade**) "Sopharma Poland" Z.O.O. - in liquidation

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33

76.17 01.10.2020

76.33 76.17 01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.33	76.17	01.10.2020

76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020
76.17	76.17	01.10.2020

30.06.2021	31.12.2020	Date of	Date of release
acquisition	from control /
Interest %	Interest %
of control	inflowing

100.00	100.00	10.11.2009
80.00	80.00	10.11.2009
100.00	100.00	18.01.2008
100.00	100.00	23.11.2010
60.00	60.00	16.10.2003
80.22	80.22	08.04.2011

OOO "Tabina" **	100.00	100.00	07.08.2012
SOOO "Brizpharm" **	63.09	59.08	31.05.2013
OOO "Sopharma Ukraine"	100.00	100.00	06.11.2014

This is a translation from Bulgarian of the consolidated financial statements of Sopharma Group for the first half of 2021.

In case of divergence Bulgarian text should prevail.

OOO "Farmacevt Plus" **	90.60	90.60	28.02.2015
TOO "Sopharma Kazakhstan"	82.00	82.00	28.02.2015
OOO "Galenapharm"**	91.98	91.98	30.06.2015
ODO "Medjel"**	77.00	77.00	18.11.2016
ODO "Alenpharm-plus"**	80.00	80.00	14.04.2017
ODO SalusLine**	90.00	90.00	26.04.2017
"Rap Pharma International" OOD	76.33	76.17	09.08.2017
ZAO "Interpharm" **	70.10	66.85	16.08.2017
"Sopharma Trading" d.o.o.	70.00	70.00	16.08.2018
(Lekovit d.o.o.**)

ООО "Zdorovei" **	85.80	85.80	07.03.2019
BООО "SpecApharmatsia" **	50.98	50.98	26.09.2019
ООО "Bellerofon" **	45.57	43.46	02.03.2020
UAB "Receus" **	100.00	100.00	14.04.2020
OOО "Zdorovei Pharm" **	100.00	-	15.02.2021
"Pharmachim" EOOD	100.00	100.00	14.04.2020
SIA "Briz Trading" **	100.00	-	15.02.2021

effective percentage of interest
indirect interest
- "Sopharma Buildings" REIT is a subsidiary by virtue of a written agreement for control concluded between "Sopharma" AD and other shareholders;
- "Sopharmacy" EOOD is a subsidiary of "Sopharma Trading" AD whereas the latter holds 100% of the capital of "Sopharmacy" EOOD;
- "Sopharmacy 2" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 2" EOOD;
- "Sopharmacy 3" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 3" EOOD;
- "Sopharmacy 4" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 4" EOOD;
- "Sopharmacy 5" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 5" EOOD;
- "Sopharmacy 6" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Soparmacy 6" EOOD;
- "Sopharmacy 7" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 7" EOOD;
- "Sopharmacy 8" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 8" EOOD;
- "Sopharmacy 9" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of "Sopharmacy 9" EOOD;
- "Sopharmacy 10" EOOD is a subsidiary of "Sopharmacy" EOOD whereas the latter holds 100% of the capital of " "Sopharmacy 10" EOOD;

This is a translation from Bulgarian of the consolidated financial statements of Sopharma Group for the first half of 2021.

In case of divergence Bulgarian text should prevail.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Original document
Permalink

Disclaimer

Sopharma AD published this content on 30 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 August 2021 12:41:08 UTC.

	1st Jan change	Capi.
SOPHARMA AD	+5.59%	545M
WALGREENS BOOTS ALLIANCE, INC.	-30.14%	15.74B
JD HEALTH INTERNATIONAL INC.	-41.56%	9.3B
MATSUKIYOCOCOKARA & CO.	-10.75%	6.02B
YIFENG PHARMACY CHAIN CO., LTD.	+6.59%	5.96B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-38.44%	5.36B
NAHDI MEDICAL COMPANY	+2.34%	4.86B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+50.00%	4.22B
CLICKS GROUP LIMITED	-12.78%	3.57B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-10.36%	3.51B

1st Jan change

Capi.

SOPHARMA AD

+5.59%

545M

WALGREENS BOOTS ALLIANCE, INC.

-30.14%

15.74B

JD HEALTH INTERNATIONAL INC.

-41.56%

9.3B

MATSUKIYOCOCOKARA & CO.

-10.75%

6.02B

YIFENG PHARMACY CHAIN CO., LTD.

+6.59%

5.96B

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

-38.44%

5.36B

NAHDI MEDICAL COMPANY

+2.34%

4.86B

CORPORATIVO FRAGUA, S.A.B. DE C.V.

+50.00%

4.22B

CLICKS GROUP LIMITED

-12.78%

3.57B

DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

-10.36%

3.51B

End-of-day quote Bulgaria S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
6.04 ^BGN	-0.98%		-0.33%	+5.59%

Feb. 29	Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023	CI

Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023	Dec. 20	CI
Sopharma AD commences an Equity Buyback Plan under the authorization approved on August 4, 2023.	Dec. 04	CI
Sopharma AD Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 30	CI
Sopharma AD Approves Distribution for the First Half of 2023, Payable on January 22, 2024	Nov. 24	CI
Sopharma Ad Proposes Distribute Dividend for First Half 2023	23-10-03	CI
Sopharma AD acquired additional 5.01% minority stake in Sopharma Buildings REIT-Sofia (BUL : SFB).	23-09-27	CI
Sopharma AD Reports Sales Results for the Month and Eight Months Ended August 2023	23-09-20	CI
Sopharma AD acquired a 2.38% stake in Sopharma Buildings REIT-Sofia.	23-09-04	CI
Sopharma AD announced that it expects to receive ?30 million in funding	23-08-30	CI
Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Sopharma AD Reports Sales Results for the Month and First Half Ended June 2023	23-07-20	CI
Sopharma AD signed an agreement to acquire Pharmanova d.o.o.	23-07-13	CI
Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2023	23-06-20	CI
Sopharma AD's Equity Buyback announced on June 5, 2018, has expired.	23-06-03	CI
Sopharma AD Declares Dividend for 2022, Payable on 31 July 2023	23-06-02	CI
Sopharma AD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Sopharma AD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Sopharma AD Reports Sales Results for the Month and Year to Date Ended February 2023	23-03-20	CI
Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
An unknown buyer acquired a 4.121376% stake in Sopharma AD from Telso AD for BGN 22.5 million.	23-02-21	CI
Donev investments holding AD completed the acquisition of additional 8.16% stake in Sopharma AD (BUL : SFA) for BGN 44.6 million.	23-02-16	CI
Sopharma AD Provides Sales Results for the Month of January 2023	23-02-06	CI
Donev investments holding AD made an offer to acquire 8.16% stake in Sopharma AD for BGN 49.5 million.	23-01-12	CI

Sopharma AD

Equities

SFA

BG11SOSOBT18

Drug Retailers

Sopharma : Information according to Annex 9 of Ordinance 2 as at 30 June 2021

Latest news about Sopharma AD

Chart Sopharma AD

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Drug Retailers